R. T. Bartus, R. L. Dean, B. Beer, and A. S. Lippa, The cholinergic hypothesis of geriatric memory dysfunction, Science, vol.217, issue.4558, pp.408-414, 1982.
DOI : 10.1126/science.7046051

P. T. Francis, A. M. Palmer, M. Snape, and G. K. Wilcock, The cholinergic hypothesis of Alzheimer's disease: a review of progress, Journal of Neurology, Neurosurgery & Psychiatry, vol.66, issue.2, pp.137-147, 1999.
DOI : 10.1136/jnnp.66.2.137

F. Mangialasche, A. Solomon, B. Winblad, P. Mecocci, and M. Kivipelto, Alzheimer's disease: clinical trials and drug development, The Lancet Neurology, vol.9, issue.7, pp.702-716, 2010.
DOI : 10.1016/S1474-4422(10)70119-8

P. Johannsen, Assessing Therapeutic Efficacy in a Progressive Disease, CNS Drugs, vol.56, issue.4, pp.311-325, 2006.
DOI : 10.1176/ajp.147.8.1049

M. N. Sabbagh, M. R. Farlow, N. Relkin, and T. G. Beach, Do cholinergic therapies have disease-modifying effects in Alzheimer???s disease?, Alzheimer's & Dementia, vol.2, issue.2, pp.118-125, 2006.
DOI : 10.1016/j.jalz.2006.02.001

E. Giacobini, Do Cholinesterase Inhibitors Have Disease-Modifying Effects in Alzheimer??s Disease?, CNS Drugs, vol.10, issue.6, pp.85-91, 2001.
DOI : 10.2165/00023210-200115020-00001

H. H. Feldman, Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe, Neurology, vol.74, issue.12, pp.956-96410, 2010.
DOI : 10.1212/WNL.0b013e3181d6476a

K. R. Krishnan, Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer???s Disease, American Journal of Psychiatry, vol.160, issue.11, pp.2003-2011, 2003.
DOI : 10.1176/appi.ajp.160.11.2003

M. Hashimoto, Does Donepezil Treatment Slow the Progression of Hippocampal Atrophy in Patients With Alzheimer???s Disease?, American Journal of Psychiatry, vol.162, issue.4, pp.676-682676, 2005.
DOI : 10.1176/appi.ajp.162.4.676

C. M. Moon, B. C. Kim, and G. W. Jeong, Effects of donepezil on brain morphometric and metabolic changes in patients with Alzheimer's disease: A DARTEL-based VBM and 1H-MRS, Magnetic Resonance Imaging, vol.34, issue.7, pp.1008-1016025, 2016.
DOI : 10.1016/j.mri.2016.04.025

N. Schuff, An MRI substudy of a donepezil clinical trial in mild cognitive impairment, Neurobiology of Aging, vol.32, issue.12, pp.2331-2341005, 2011.
DOI : 10.1016/j.neurobiolaging.2010.04.005

C. R. Jack, Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI, Neurobiology of Aging, vol.29, issue.9, pp.1285-1295, 2008.
DOI : 10.1016/j.neurobiolaging.2007.03.004

B. Dubois, Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease, Alzheimer's & Dementia, vol.11, issue.9, p.3, 2015.
DOI : 10.1016/j.jalz.2014.10.003

R. S. Doody, Donepezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trial, Neurology, vol.72, issue.18, pp.1555-1561, 2009.
DOI : 10.1212/01.wnl.0000344650.95823.03

J. Birks and L. Flicker, Donepezil for mild cognitive impairment, Cochrane Database Syst Rev, vol.273, issue.3, pp.10-1002, 2006.
DOI : 10.1212/WNL.34.7.939

E. Cavedo, Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer???s Disease, The Journal of Clinical Psychiatry, vol.77, issue.12, pp.10-4088, 2016.
DOI : 10.4088/JCP.15m10413
URL : https://hal.archives-ouvertes.fr/hal-01388951

M. M. Mesulam, The cholinergic innervation of the human cerebral cortex, Prog Brain Res, vol.145, pp.67-7845004, 2004.
DOI : 10.1016/S0079-6123(03)45004-8

M. M. Mesulam, Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease, Journal of Comparative Neurology, vol.313, issue.Suppl, pp.4124-414410, 2013.
DOI : 10.1002/cne.903130207

M. M. Mesulam, E. J. Mufson, A. I. Levey, and B. H. Wainer, Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry, Neuroscience, vol.12, issue.3, pp.669-686, 1984.
DOI : 10.1016/0306-4522(84)90163-5

S. J. Teipel, The cholinergic system in mild cognitive impairment and Alzheimer's disease: An in vivo MRI and DTI study, Human Brain Mapping, vol.42, issue.Part 3, pp.1349-1362, 2011.
DOI : 10.1016/j.neuroimage.2008.05.055

M. Grothe, H. Heinsen, and S. J. Teipel, Atrophy of the Cholinergic Basal Forebrain Over the Adult Age Range and in Early Stages of Alzheimer's Disease, Biological Psychiatry, vol.71, issue.9, pp.805-813, 2012.
DOI : 10.1016/j.biopsych.2011.06.019

M. Grothe, Reduction of Basal Forebrain Cholinergic System Parallels Cognitive Impairment in Patients at High Risk of Developing Alzheimer's Disease, Cerebral Cortex, vol.20, issue.7, pp.1685-169510, 2010.
DOI : 10.1093/cercor/bhp232

M. Grothe, H. Heinsen, and S. Teipel, Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease, Neurobiology of Aging, vol.34, issue.4, pp.1210-1220018, 2013.
DOI : 10.1016/j.neurobiolaging.2012.10.018

I. Kilimann, Subregional Basal Forebrain Atrophy in Alzheimer's Disease: A Multicenter Study, J Alzheimers Dis, pp.10-3233, 2014.

O. J. Vogels, Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease, Neurobiology of Aging, vol.11, issue.1, pp.3-13, 1990.
DOI : 10.1016/0197-4580(90)90056-6

T. W. Schmitz and R. Nathan-spreng, Alzheimer's Disease Neuroimaging, I. Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology, Nat Commun, vol.7, pp.10-1038, 2016.

S. Teipel, Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease, Neurobiology of Aging, vol.35, issue.3, pp.482-491029, 2014.
DOI : 10.1016/j.neurobiolaging.2013.09.029

M. J. Grothe, Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects, Alzheimer's & Dementia, vol.10, issue.5, p.11, 2014.
DOI : 10.1016/j.jalz.2013.09.011

G. M. Kerbler, Basal forebrain atrophy correlates with amyloid ?? burden in Alzheimer's disease, NeuroImage: Clinical, vol.7, pp.105-113, 2015.
DOI : 10.1016/j.nicl.2014.11.015

G. M. Kerbler, Basal Forebrain Atrophy Contributes to Allocentric Navigation Impairment in Alzheimer???s Disease Patients, Frontiers in Aging Neuroscience, vol.42, issue.185, p.185, 2015.
DOI : 10.1016/j.neuroimage.2008.05.055

B. Dubois, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS???ADRDA criteria, The Lancet Neurology, vol.6, issue.8, pp.734-74610, 2007.
DOI : 10.1016/S1474-4422(07)70178-3

T. Arendt, M. K. Bruckner, M. Morawski, C. Jager, and H. J. Gertz, Early neurone loss in Alzheimer???s disease: cortical or subcortical?, Acta Neuropathologica Communications, vol.10, issue.2, pp.10-1186, 2015.
DOI : 10.1016/S1474-4422(11)70156-9

S. J. Teipel, Measurement of basal forebrain atrophy in Alzheimer's disease using MRI, Brain, vol.128, issue.11, pp.2626-2644, 2005.
DOI : 10.1093/brain/awh589

M. J. Grothe, Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment, Cerebral Cortex, vol.26, issue.6, pp.2411-2426, 2016.
DOI : 10.1093/cercor/bhv062

D. Wolf, Association of basal forebrain volumes and cognition in normal aging, Neuropsychologia, vol.53, pp.54-63, 2014.
DOI : 10.1016/j.neuropsychologia.2013.11.002

P. Bentley, M. Husain, and R. J. Dolan, Effects of Cholinergic Enhancement on Visual Stimulation, Spatial Attention, and Spatial Working Memory, Neuron, vol.41, issue.6, pp.969-982, 2004.
DOI : 10.1016/S0896-6273(04)00145-X

S. Duzel, Basal forebrain integrity and cognitive memory profile in healthy aging, Brain Research, vol.1308, pp.124-136048, 2010.
DOI : 10.1016/j.brainres.2009.10.048

T. Fujii, The Role of the Basal Forebrain in Episodic Memory Retrieval: A Positron Emission Tomography Study, NeuroImage, vol.15, issue.3, pp.501-5080995, 2001.
DOI : 10.1006/nimg.2001.0995

G. M. Kerbler, Basal forebrain atrophy correlates with amyloid ?? burden in Alzheimer's disease, NeuroImage: Clinical, vol.7, pp.105-113, 2015.
DOI : 10.1016/j.nicl.2014.11.015

E. K. Perry, Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia., BMJ, vol.2, issue.6150, pp.1457-1459, 1978.
DOI : 10.1136/bmj.2.6150.1457

T. Arendt, V. Bigl, A. Tennstedt, and A. Arendt, Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease, Neuroscience Letters, vol.48, issue.1, pp.81-85, 1984.
DOI : 10.1016/0304-3940(84)90292-1

P. E. Potter, Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer???s disease, Acta Neuropathologica, vol.19, issue.Suppl 1, pp.49-6010, 2011.
DOI : 10.1016/j.neurobiolaging.2006.06.001

Y. Tanaka, H. Hanyu, H. Sakurai, M. Takasaki, and K. Abe, Atrophy of the Substantia innominata on Magnetic Resonance Imaging Predicts Response to Donepezil Treatment in Alzheimer???s Disease Patients, Dementia and Geriatric Cognitive Disorders, vol.16, issue.3, pp.119-12570998, 2003.
DOI : 10.1159/000070998

S. J. Teipel, Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease, Neuropharmacology, vol.108, pp.128-135005, 2016.
DOI : 10.1016/j.neuropharm.2016.02.005

N. Schuff, MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers, Brain, vol.132, issue.4, pp.1067-107710, 2009.
DOI : 10.1093/brain/awp007

S. J. Teipel, Effects of donepezil on cortical metabolic response to activation during 18FDG-PET in Alzheimer???s disease: a double-blind cross-over trial, Psychopharmacology, vol.11, issue.1, pp.86-9410, 2006.
DOI : 10.1212/WNL.56.3.408

J. S. Goveas, Recovery of hippocampal network connectivity correlates with cognitive improvement in mild alzheimer's disease patients treated with donepezil assessed by resting-state fMRI, Journal of Magnetic Resonance Imaging, vol.61, issue.e159, pp.764-77310, 2011.
DOI : 10.1001/archneur.61.12.1852

C. Sole-padulles, Donepezil Treatment Stabilizes Functional Connectivity During Resting State and Brain Activity During Memory Encoding in Alzheimer???s Disease, Journal of Clinical Psychopharmacology, vol.33, issue.2, pp.199-20510, 2013.
DOI : 10.1097/JCP.0b013e3182825bfd

A. L. Bokde, Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study, Psychiatry Research: Neuroimaging, vol.249, pp.84-90018, 2016.
DOI : 10.1016/j.pscychresns.2016.01.018

M. M. Mesulam, C. Geula, M. A. Bothwell, and L. B. Hersh, Human reticular formation: Cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons, The Journal of Comparative Neurology, vol.22, issue.4, pp.611-63310, 1989.
DOI : 10.1113/jphysiol.1967.sp008326

T. Oda, Donepezil Potentiates Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells, Journal of Pharmacological Sciences, vol.104, issue.4, pp.349-354, 2007.
DOI : 10.1254/jphs.FP0070563

D. S. Auld, S. Kar, and R. Quirion, ??-Amyloid peptides as direct cholinergic neuromodulators: a missing link?, Trends in Neurosciences, vol.21, issue.1, pp.43-49, 1998.
DOI : 10.1016/S0166-2236(97)01144-2

H. W. Querfurth and F. M. Laferla, Alzheimer's Disease, New England Journal of Medicine, vol.362, issue.4, pp.329-34410, 2010.
DOI : 10.1056/NEJMra0909142

J. M. Rubio-perez and J. M. Morillas-ruiz, A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines, The Scientific World Journal, vol.287, issue.24, p.756357, 2012.
DOI : 10.1023/A:1007614613771

D. Doens and P. L. Fernández, Microglia receptors and their implications in the response to amyloid ?? for Alzheimer???s disease pathogenesis, Journal of Neuroinflammation, vol.11, issue.1, pp.10-1186, 2014.
DOI : 10.1186/1742-2094-8-11

S. M. Li, M. M. Xu, and P. Progress, in mechanisms of acetylcholinesterase inhibitors and memantine for the treatment of Alzheimer's disease, Neuroimmunol Neuroinflammation, vol.2, pp.274-280, 2015.

Y. Yoshiyama, A. Kojima, C. Ishikawa, and K. Arai, Anti-Inflammatory Action of Donepezil Ameliorates Tau Pathology, Synaptic Loss, and Neurodegeneration in a Tauopathy Mouse Model, Journal of Alzheimer's Disease, vol.22, issue.1, pp.295-30610, 2010.
DOI : 10.3233/JAD-2010-100681

E. Rolandi, G. B. Frisoni, and E. Cavedo, Efficacy of lifestyle interventions on clinical and neuroimaging outcomes in elderly, Ageing Research Reviews, vol.25, pp.1-12, 2016.
DOI : 10.1016/j.arr.2015.11.003

B. T. Gold, Lifelong bilingualism and neural reserve against Alzheimer's disease: A review of findings and potential mechanisms, Behavioural Brain Research, vol.281, pp.9-15006, 2015.
DOI : 10.1016/j.bbr.2014.12.006

J. Thomas, C. J. Thomas, J. Radcliffe, and C. Itsiopoulos, Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer???s Disease, BioMed Research International, vol.77, issue.4, pp.10-1155172801, 2015.
DOI : 10.1136/jnnp-2012-304792

B. Borroni, ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model, European Neuropsychopharmacology, vol.12, issue.3, pp.195-200, 2002.
DOI : 10.1016/S0924-977X(02)00013-5

M. Chupin, Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: Method and validation, NeuroImage, vol.46, issue.3, pp.749-761, 2009.
DOI : 10.1016/j.neuroimage.2009.02.013
URL : https://hal.archives-ouvertes.fr/hal-00805390

J. Ashburner and G. Ridgway, Symmetric diffeomorphic modeling of longitudinal structural MRI, Frontiers in Neuroscience, vol.6, issue.197, p.197, 2012.
DOI : 10.3389/fnins.2012.00197

M. M. Mesulam, E. J. Mufson, A. I. Levey, and B. H. Wainer, Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey, The Journal of Comparative Neurology, vol.8, issue.2, pp.170-197902140206, 1983.
DOI : 10.1177/26.1.413864

M. M. Mesulam and C. Geula, Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase, The Journal of Comparative Neurology, vol.7, issue.2, pp.216-24010, 1988.
DOI : 10.1177/34.11.2430009

I. Kilimann, Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study, J Alzheimers Dis, vol.40, pp.687-70010, 2014.

C. and G. De-chauliac, 19 Lyon 1 university, Hospices Civils de Lyon, hôpital neurologique, service de neurologie D, 17 Centre Mémoire/Centre de Recherche Clinique ? Gérontopôle, Hôpital Casselardit